$59.95
-0.74-1.22%
Pre-Market: 7:16 PM EDT
Comments
Loading...
Novonesis (Novozymes) B Earnings Estimates, EPS & Revenue | OTC:NVZMY | Benzinga
Novonesis (Novozymes) B reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 26
EPS
$1.390
Quarterly Revenue
$4.15B
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$3.83B
Analyze the earnings history of Novonesis (Novozymes) B using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVZMY | Novozymes | — | — | $1.39 | — | — | — | $4.15B | — | 02/26/2025 | Get Alert |
| NVZMY | Novozymes | — | — | $0.69 | — | — | — | $2.10B | — | 08/27/2024 | Get Alert |
| NVZMY | Novozymes | $0.43 | $0.44 | $0.36 | -18.18% | $606.10M | $674.70M | $664.23M | -1.55% | 02/01/2024 | Get Alert |
| NVZMY | Novozymes | $0.56 | $0.42 | $0.49 | 16.67% | $591.68M | $634.28M | $650.51M | 2.56% | 10/26/2023 | Get Alert |
| NVZMY | Novozymes | $0.42 | $0.42 | $0.32 | -23.81% | $614.04M | $632.02M | $616.52M | -2.45% | 08/09/2023 | Get Alert |
| NVZMY | Novozymes | $0.45 | $0.44 | $0.41 | -6.82% | $659.40M | $662.60M | $666.31M | 0.56% | 04/26/2023 | Get Alert |
| NVZMY | Novozymes | $0.34 | $0.41 | $0.43 | 4.88% | $589.85M | $671.94M | $606.10M | -9.80% | 01/26/2023 | Get Alert |
| NVZMY | Novozymes | $0.48 | $0.62 | $0.56 | -9.68% | $596.04M | $622.40M | $591.68M | -4.93% | 11/03/2022 | Get Alert |
| NVZMY | Novozymes | $0.46 | — | $0.42 | — | $579.96M | — | $614.04M | — | 08/11/2022 | Get Alert |
| NVZMY | Novozymes | $0.51 | — | $0.45 | — | $611.99M | — | $659.40M | — | 04/27/2022 | Get Alert |
| NVZMY | Novozymes | $0.37 | $0.36 | $0.34 | -5.56% | $551.36M | $576.38M | $589.85M | 2.34% | 02/01/2022 | Get Alert |
| NVZMY | Novozymes | $0.40 | $0.40 | $0.48 | 20.00% | $538.67M | $582.09M | $596.04M | 2.40% | 10/27/2021 | Get Alert |
| NVZMY | Novozymes | $0.34 | — | $0.46 | — | $494.68M | — | $579.96M | — | 08/12/2021 | Get Alert |
| NVZMY | Novozymes | $0.42 | — | $0.51 | — | $558.41M | — | $611.99M | — | 04/27/2021 | Get Alert |
| NVZMY | Novozymes | $0.49 | — | $0.37 | — | $559.65M | — | $551.36M | — | 02/02/2021 | Get Alert |
| NVZMY | Novozymes | $0.33 | $0.63 | $0.40 | -36.51% | $555.60M | $289.03M | $538.67M | 86.37% | 10/21/2020 | Get Alert |
| NVZMY | Novozymes | $0.47 | — | $0.34 | — | $519.33M | — | $494.68M | — | 08/12/2020 | Get Alert |
| NVZMY | Novozymes | $0.37 | — | $0.42 | — | $529.83M | — | $558.41M | — | 04/29/2020 | Get Alert |
Novonesis (Novozymes) B (NVZMY) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2024-02-01 | $0.36 | $0.44 | -18.2 % |
| Q3 | 2023-10-26 | $0.49 | $0.42 | 16.7 % |
| Q2 | 2023-08-09 | $0.32 | $0.42 | -23.8 % |
| Q1 | 2023-04-26 | $0.41 | $0.44 | -6.82 % |
Novonesis (Novozymes) B (NVZMY) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2024-02-01 | $664.23M | $674.70M | -1.55 % |
| Q3 | 2023-10-26 | $650.51M | $634.28M | 2.56 % |
| Q2 | 2023-08-09 | $616.52M | $632.02M | -2.45 % |
| Q1 | 2023-04-26 | $666.31M | $662.60M | 0.56 % |
FAQ
When is Novonesis (Novozymes) B (OTCPK:NVZMY) reporting earnings?
Novonesis (Novozymes) B (NVZMY) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 26, 2025 for FY.
What were the latest earnings per share (EPS) for Novonesis (Novozymes) B (OTCPK:NVZMY)?
Novonesis (Novozymes) B (NVZMY) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 26, 2025 for FY and the Actual EPS was $1.39, which beat the estimate of $0.00.
What were Novonesis (Novozymes) B’s (OTCPK:NVZMY) revenues?
Novonesis (Novozymes) B (NVZMY) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 26, 2025 for FY and the Actual Revenue was $4.1B, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.